Literature DB >> 29877104

Carvacrol activity & morphological changes in Mycobacterium tuberculosis.

Sandra S Nakamura de Vasconcelos1, Katiany R Caleffi-Ferracioli1, Laíse A Hegeto1, Vanessa P Baldin1, Celso V Nakamura2, Talitha F Stefanello2, Gisele de Freitas Gauze3, Diego As Yamazaki3, Regiane Bl Scodro1, Vera Ld Siqueira1, Rosilene F Cardoso1.   

Abstract

AIM: Evaluating carvacrol, derivatives and carvacrol plus anti-TB (anti-tuberculous) drug combination activities in Mycobacterium tuberculosis as well as carvacrol cytotoxicity, efflux pump inhibitor activity and morphological changes in M. tuberculosis H37Rv.
METHODS: Carvacrol (CAR) and derivatives' activities were determined by resazurin microtiter assay and drug interaction by resazurin drug combination microtiter. Carvacrol cytotoxicity in VERO cells and efflux pumps inhibitor activity by ethidium bromide assay were determined and scanning electron microscopy performed.
RESULTS: Carvacrol MIC ranged from 19 to 156 μg/ml and carvacrol plus rifampicin combination showed synergistic effect in clinical isolates. No anti-M. tuberculosis activity improvement was observed with carvacrol derivatives. Carvacrol showed to be selective for M. tuberculosis, to have efflux pumps activity and to induce rough bacillary and agglomerates.
CONCLUSION: Carvacrol shows good anti-M. tuberculosis activity and synergism with rifampicin.

Entities:  

Keywords:  MIC; Mycobacterium tuberculosis; carvacrol; derivatives; efflux pump; monoterpene; resistance; rifampicin; scanning electron microscopy; synergism

Mesh:

Substances:

Year:  2018        PMID: 29877104     DOI: 10.2217/fmb-2017-0232

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  1 in total

Review 1.  Anticonvulsant Essential Oils and Their Relationship with Oxidative Stress in Epilepsy.

Authors:  Diogo Vilar da Fonsêca; Carlos da Silva Maia Bezerra Filho; Tamires Cardoso Lima; Reinaldo Nóbrega de Almeida; Damião Pergentino de Sousa
Journal:  Biomolecules       Date:  2019-12-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.